Aliaksandr Zhurauliou

Surgical Pathologist at Russian National Medical Research Center of Oncology

[Aliaksandr Zhurauliou @AliaksZhur]

Extremely well-differentiated adenocarcinoma with a neuroendocrine tumor in the stomach. Intestinal metaplasia-like glands of the adenocarcinoma.
#GIpath #NET #MINEN

[Ahmed Shah, MD MSc @AhmedShahMD]

🚨We’re looking at the first reported primary cutaneous spindle cell sarcoma with FN1-rearrangement. Unlike other FN1-fusion tumors like PMTs and CCMNs, this one truly stands apart, making it a unique diagnostic challenge.
Read more: https://t.co/h60kEPsJcu
#dermtwitter #BSTPath

[Aliaksandr Zhurauliou @AliaksZhur]

Melanosis of stomach, SOX10 negative. Patient with metastatic melanoma after immunotherapy #melanoma #GIpath

[Aliaksandr Zhurauliou @AliaksZhur]

@ZSarrafan @UTMB_Pathology @SuiminQ TTF1

[Aliaksandr Zhurauliou @AliaksZhur]

Breast adenomyoepithelioma with papillary intraductal growth and incidental finding of DCIS after IHC #breastpath #insitu #DCIS #adenomyoepithelioma #AME

[Liang Cheng, MD @LiangChengMD]

Happy Friday! Happy Holidays!  I’m delighted to share this insightful review article, published this week in Histopathology @Histo_Journal , authored by Professor Yihong Wang and colleagues @DrSGraff Congratulations!

Summary: Recent advances in breast cancer research are unlocking new molecular applications for diagnosis & treatment. Personalized therapies like CDK4/6 inhibitors, immune checkpoint inhibitors, & PIK3CA inhibitors are reshaping care for hormone receptor-positive, HER2-negative cancers. Biomarkers related to drug resistance & the tumor microenvironment (TILs, PD-L1) are essential for treatment decisions. Integrating molecular data with pathology will lead to more accurate diagnoses & better outcomes.

The article is available at the following link:
https://t.co/fGwqnKUyoh
@BrownUCancer
@BrownUniversity
@BrownMedicine
@BrownPathology
@BrownOncology

[Human Pathology @Human_Pathology]

New in #HumPathol: High-Grade B-cell Lymphomas: Double Hit and Non-Double Hit. https://t.co/nlWhb5d5aC #pathology #PathTwitter #PathX #hemepath

[Aliaksandr Zhurauliou @AliaksZhur]

@_Wondweson64 @noureldin629 Ki67 near 75%, so finally it was called large cell NEC

[Aliaksandr Zhurauliou @AliaksZhur]

Big combo from the small intestine:
Neuroendocrine tumor
Mucinous adenocarcinoma
T cell/histiocyte rich large B cell lymphoma
#GIpath #hempath #NEO #MINEN #THRLBCL

[Aliaksandr Zhurauliou @AliaksZhur]

@noureldin629 MINEN and lymphoma

[Aliaksandr Zhurauliou @AliaksZhur]

Focal myogenin in desmoid-type fibromatosis, potential pitfall
#BSTpath #myogenin #desmoid #fibromatosis #spindlecellRMS

[Aliaksandr Zhurauliou @AliaksZhur]

@SwagataKaran3 @DanGrahamMD Discohesive rhabdoid cells + zero immunophenotype

[Aliaksandr Zhurauliou @AliaksZhur]

My first experience with NUT1-positive colorectal sarcoma
#GIpath #BSTpath #NUTM1 #NUT1

[Springer Pathology @SpringerPath]

ERBB2/ ERBB3-mutated S100/ SOX10-positive unclassified high-grade uterine sarcoma: first detailed description of a novel entity https://t.co/V4B0nbUFcj

[Aliaksandr Zhurauliou @AliaksZhur]

"You might not have seen it, but it might have seen you" Dr. Nielsen about PRRX::NCOAx‐rearranged fibroblastic tumor at ECP2024
#BSTpath #ECP2024

[Ioana Manole @ioanam92]

Acral fibrochondromyxoid Tumor (AFCM):
✅benign
✅very rare digital neoplsma, exclusively fingers and toes
✅ median age: 42 years
✅M>W
✅ may mimic chondroma and should be considered in the differential diagnosis
✅IHC:
➕EMA, ERG, CD 34
➖S100, SMA, SOX 10, PanCK

[Pathology mcqs @Pathology_mcqs]

🦴✨ Understanding Bone Tumors at the Genetic Level
#BoneTumors #Genetics #Pathology #MedicalEducation #CancerResearch #Osteosarcoma #EwingSarcoma #Chondrosarcoma #Histopathology #PathologyMCQ #MedicalLearning #MedicalBlog #NEETSS #FRCPath

[Aliaksandr Zhurauliou @AliaksZhur]

@RazaHoda Nice case! Did you make AR and AMACR for this? I see some apocrine features

[Histopathology @Histo_Journal]

Special Edition on ‘Practical Advances in Breast Pathology’! #breastpath https://t.co/j2ntZZtUX7

[Xenia Parisi, MD @XeniaParisi]

Please join us for Bone Marrow Unknowns 8/7 @9:15am CT! @sanamloghavi will be hosting the 1st conference after our July hiatus.
Slides and Hx below! Meeting link forthcoming.
#hemepath #pathtwitter
@PaulYoungMD1 @EShuyu @kirillLyapichev
@SibaElHussein